ZEB1 integrates stemness, differentiation blockade and immune suppression to orchestrate osteosarcoma aggressiveness.
Saved in:
| Title: | ZEB1 integrates stemness, differentiation blockade and immune suppression to orchestrate osteosarcoma aggressiveness. |
|---|---|
| Authors: | Zaccaria A; Department of Experimental Oncology, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy., Cascini C; Department of Experimental Oncology, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy., Ratti C; Department of Experimental Oncology, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy., Botti L; Department of Experimental Oncology, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy., Pernici D; Department of Experimental Oncology, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy., Cancila V; Department of Health Sciences, Tumor Immunology Unit, University of Palermo School of Medicine, Palermo, 90134, Italy., Armiraglio E; Department of Pathology, Istituto Ortopedico Gaetano Pini, Milan, 20122, Italy., Parafioriti A; Department of Pathology, Istituto Ortopedico Gaetano Pini, Milan, 20122, Italy., Meazza C; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Sangaletti S; Department of Experimental Oncology, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy., Tripodo C; Advanced Pathology Laboratory, IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, 20139, Italy., Scotlandi K; Laboratory of Experimental Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, 40136, Italy., Colombo MP; Department of Experimental Oncology, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy., Lecis D; Department of Experimental Oncology, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy., Chiodoni C; Department of Experimental Oncology, Molecular Immunology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, Milan, 20133, Italy. claudia.chiodoni@istitutotumori.mi.it. |
| Source: | Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
